Real-World Evidence: Longitudinal Pain Interference & Opioid Sparing across 32,000+ Clinical Encounters
Real-World Evidence: Longitudinal Pain Interference & Opioid Sparing across 32,000+ Clinical Encounters
Longitudinal real-world evidence from the CED Clinic clinical registry evaluating symptom trajectory, tolerance prevention, and opioid reduction protocols across outpatient cohorts. Derived from longitudinal physician evaluations across 81,008 unique clinical cohorts and 130,447 structured follow-up encounters at CED Clinic, informed by Dr. Benjamin Caplan’s career oversight of 350,000+ patient evaluations.
Methodology & Observational Grounding
Unlike traditional pharmaceutical clinical trials that restrict inclusion criteria to single-diagnosis participants devoid of concurrent medications, the CED Clinic Real-World Evidence Registry captures the complex clinical reality of outpatient cannabinoid medicine. Patients in this cohort were systematically evaluated under board-certified physician supervision, with structured longitudinal tracking of symptom burden, medication de-escalation, adverse event incidence, and chemovar responsiveness.
What does real-world evidence show regarding cannabinoids for Chronic Pain & Neuropathy?
Real-world registry data demonstrates that optimal opioid-sparing analgesia is achieved not by escalating single-molecule THC concentrations, but through consistent daytime anti-inflammatory tone (CBD/CBG) combined with precise, low-dose nighttime micro-titration to restore restorative slow-wave sleep.
What is the clinical scale and data provenance of this Chronic Pain & Neuropathy analysis?
This analysis synthesizes real-world clinical observations from Dr. Benjamin Caplan, MD, who has overseen more than 350,000 patient evaluations across his career (including supervising 250,000+ patients as former Chief Medical Officer of Canna Care Docs). The specific dataset reflects 81,008 outpatient cohorts and 130,447 structured clinical visits tracked in the CED Clinic Clinical Registry.
Get the next evidence review in your inbox
Plain-language summaries of the newest cannabis research, written by a physician. Free to read, and you can unsubscribe at any time.
Join the growing cannabis community. Free. One-click subscribe. Delivered by Substack.
“Real-world registry data demonstrates that optimal opioid-sparing analgesia is achieved not by escalating single-molecule THC concentrations, but through consistent daytime anti-inflammatory tone (CBD/CBG) combined with precise, low-dose nighttime micro-titration to restore restorative slow-wave sleep.”